Aus Bio Ltd. Researcher Wen-Yang Wu

Wen-Yang Wu, executive director of research and development at Aus Bio Ltd., poses for a photograph at the company's laboratory in Melbourne, Australia, on Tuesday, Feb. 6, 2018. Wu, who helped discover GlaxoSmithKline Plc's flu drug Relenza, is developing a novel way of preventing flu viruses from infecting respiratory cells. It works by reshaping the hemagglutinin, another protein on the surface of the virus, by creating a low pH environment that mimics the change that occurs after a virus invades a host cell, Wu said. Photographer: Carla Gottgens/Bloomberg via Getty Images
Wen-Yang Wu, executive director of research and development at Aus Bio Ltd., poses for a photograph at the company's laboratory in Melbourne, Australia, on Tuesday, Feb. 6, 2018. Wu, who helped discover GlaxoSmithKline Plc's flu drug Relenza, is developing a novel way of preventing flu viruses from infecting respiratory cells. It works by reshaping the hemagglutinin, another protein on the surface of the virus, by creating a low pH environment that mimics the change that occurs after a virus invades a host cell, Wu said. Photographer: Carla Gottgens/Bloomberg via Getty Images
Aus Bio Ltd. Researcher Wen-Yang Wu
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
AR$ 208.500,00
ARS
Getty ImagesAus Bio Ltd. Researcher Wen-Yang Wu, Fotografía de noticiasAus Bio Ltd. Researcher Wen-Yang Wu, Fotografía de noticiasAus Bio Ltd. Researcher Wen-Yang Wu Consigue fotografías de noticias de alta resolución y gran calidad en Getty ImagesProduct #:916059336
AR$329.200AR$88.100
Getty Images
In stock

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial n.º:
916059336
Colección:
Bloomberg
Fecha de creación:
06 de febrero de 2018
Fecha de subida:
Tipo de licencia:
Con derechos gestionados
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
Bloomberg
Nombre del objeto:
AUSTRALIA AUSBIO
Tamaño máx. archivo:
4288 x 2854 px (36,31 x 24,16 cm) - 300 dpi - 4 MB